ArticlePediatric research2026
Necrotizing enterocolitis is exacerbated through SUCNR1/HIF-1α/BNIP3 axis-mediated succinate-induced intestinal epithelial cell apoptosis.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo elucidate the mechanism by which succinate exacerbates intestinal injury in necrotizing enterocolitis (NEC).
methodsSuccinate levels were measured in newborns and mice with NEC. Intestinal epithelial damage and apoptosis were evaluated in NEC models. The expression of succinate receptor 1 (SUCNR1), hypoxia-inducible factor 1-alpha (HIF-1α), and BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3) was inhibited, and the associated pathway proteins were quantified. The regulatory relationship between HIF-1α and BNIP3 was elucidated using ChIP‒qPCR and dual-luciferase reporter gene assays.
resultsCompared with those in the control group, succinate levels were elevated in the feces of NEC neonates and the intestinal tissue of NEC mice. Succinate treatment exacerbated intestinal epithelial damage, increasing Bax and cleaved caspase-3 expression, as well as the cleaved caspase-9 to pro-caspase-9 ratio, while downregulating Bcl-2 expression. Additionally, succinate increased mitochondrial membrane potential depolarization and cytochrome c (Cyt c) efflux in NEC cell models. The inhibition of SUCNR1, HIF-1α, or BNIP3 may mitigate intestinal epithelial cell apoptosis (P < 0.05). HIF-1α regulated BNIP3 expression, as shown by ChIP‒qPCR and dual luciferase assays.
conclusionSuccinate may exacerbate the apoptosis of intestinal epithelial cells in an NEC model through the SUCNR1/HIF-1α/BNIP3 pathway. IMPACT: The pathogenesis of NEC remains incompletely understood; however, elevated succinate levels are recognized as an important contributor to its development and progression. Succinate intervention exacerbated intestinal epithelial damage and intestinal epithelial cell apoptosis in the NEC model through the SUCNR1/HIF-1α/BNIP3 pathway. Succinate may serve not only as a potential therapeutic target but also as a novel biomarker for early diagnosis and disease monitoring of NEC. Additionally, future research should focus on integrating microbial-metabolite interaction analyses, advancing the clinical application of metabolic interventions, and improving the prognosis of NEC infants.
Identifiers
42045567What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.